Concepedia

Publication | Closed Access

The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis

DOI

34

Citations

20

References

2006

Year

Eiji Torikai, Yasunori Kageyama, Masaaki Takahashi, Masakatsu Suzuki, Tetsuya Ichikawa, Tetsuyuki Nagafusa, Akira Nagano
Lara D. Veeken

Abstract

Infliximab therapy may inhibit generalized bone loss in patients with RA. NTX is a more sensitive marker than DPD.

References

YearCitations

Page 1